HSDT - Helius Medical Technologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 544.81M
Enterprise Value 331.73M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)26.78
Price/Book (mrq)3.55
Enterprise Value/Revenue 318.97
Enterprise Value/EBITDA 6-1.40

Trading Information

Stock Price History

Beta (3Y Monthly) -1.58
52-Week Change 3-82.12%
S&P500 52-Week Change 33.36%
52 Week High 310.7600
52 Week Low 31.7300
50-Day Moving Average 31.9569
200-Day Moving Average 33.1455

Share Statistics

Avg Vol (3 month) 381.82k
Avg Vol (10 day) 348.07k
Shares Outstanding 525.9M
Float 18.83M
% Held by Insiders 127.62%
% Held by Institutions 116.27%
Shares Short (Aug 15, 2019) 41.01M
Short Ratio (Aug 15, 2019) 426.98
Short % of Float (Aug 15, 2019) 44.97%
Short % of Shares Outstanding (Aug 15, 2019) 43.89%
Shares Short (prior month Jul 15, 2019) 41.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Jan 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,362.04%

Management Effectiveness

Return on Assets (ttm)-80.73%
Return on Equity (ttm)-2,330.32%

Income Statement

Revenue (ttm)1.67M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)478k
EBITDA -22.7M
Net Income Avi to Common (ttm)-8.49M
Diluted EPS (ttm)-0.3410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.31M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)710k
Total Debt/Equity (mrq)5.55
Current Ratio (mrq)3.40
Book Value Per Share (mrq)0.49

Cash Flow Statement

Operating Cash Flow (ttm)-19.71M
Levered Free Cash Flow (ttm)-37.37M